Bellicum Pharmaceuticals Company

Bellicum is engineering high-performance cellular immunotherapies and unleashing their power against a wide range of cancers, impacting more patients than ever.
Technology: Сancer Diagnostics
Industry: Genomic and Epigenominc Instabillity
Headquarters: United States
Founded Date: 01.07.2004
Funding Status: IPO
Estimated Revenue: Less than $1M

Visit Website
Register and Claim Ownership